Literature DB >> 35035738

Analysis of the influencing factors of the clinical effect of respiratory humidifier in treating AIDS complicated with severe Pneumocystis jiroveci pneumonia.

Qi Cao1, Wei Zeng2, Jingmin Nie1, Yongjun Ye3, Yanchao Chen4.   

Abstract

OBJECTIVE: To analyze the factors influencing the clinical effect of using respiratory humidifier in patients with AIDS complicated with severe Pneumocystis jiroveci pneumonia (PCP).
METHODS: According to the treatment results, AIDS patients with severe PCP were divided into two groups, successful group (n=68) and failure group (n=94), to compare the early ventilation changes between the two groups.
RESULTS: The ICU ratio of the successful group was lower than that of the failure group (P<0.05). The respiratory frequency, heart rate, PaO2, C-reactive protein and SOFA score of the successful group were lower than those in the failure group (P<0.05), while SpO2, FiO2, PaO2/FiO2, SpO2/FiO2, Rox index and IL-10 levels were increased in the successful group (P<0.05). The successful group had higher IL-6 and IL-1β level than that of the failure group. The levels of IL-8 were decreased (P<0.05). The success of respiratory humidifier was negatively correlated with the score of SOFA (P<0.05).
CONCLUSION: The clinical effect of respiratory humidifier in the treatment of AIDS patients with severe PCP was related to PaO2/FiO2, PaO2, ROX index, SOFA score, and IL-6 and IL-8 levels. AJTR
Copyright © 2021.

Entities:  

Keywords:  AIDS; Pneumocystis jiroveci pneumonia; clinical; respiratory humidifier

Year:  2021        PMID: 35035738      PMCID: PMC8748140     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  20 in total

1.  Dyspnea in homosexual male patients: throwback to an occasionally forgotten but severe clinical presentation of HIV/AIDS.

Authors:  Koen Verbeke; Roel Verbuyst; Christiane Brands; Hans Slabbynck
Journal:  Acta Clin Belg       Date:  2019-05-25       Impact factor: 1.264

2.  An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.

Authors:  Oriol Roca; Berta Caralt; Jonathan Messika; Manuel Samper; Benjamin Sztrymf; Gonzalo Hernández; Marina García-de-Acilu; Jean-Pierre Frat; Joan R Masclans; Jean-Damien Ricard
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

3.  Impact of High Flow Nasal Cannula Therapy on Oral Feeding in Very Low Birth Weight Infants with Chronic Lung Disease.

Authors:  Daisuke Shimizu; Shunsuke Araki; Masaru Kawamura; Mami Kuwamura; Shutaro Suga; Fuyu Miyake; Shun Ichikawa; Tadamune Kinjo; Koichi Kusuhara
Journal:  J UOEH       Date:  2019

4.  Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure. A single-centre case series.

Authors:  Francesca Simioli; Anna Annunziata; Gerardo Langella; Giorgio E Polistina; Maria Martino; Giuseppe Fiorentino
Journal:  Anaesthesiol Intensive Ther       Date:  2020

5.  High flow nasal cannula oxygen versus noninvasive ventilation in adult acute respiratory failure: a systematic review of randomized-controlled trials.

Authors:  Lim Beng Leong; Ng Wei Ming; Lee Wei Feng
Journal:  Eur J Emerg Med       Date:  2019-02       Impact factor: 2.799

6.  Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality.

Authors:  Yogita Singh; Bijay Ranjan Mirdha; Randeep Guleria; Sushil K Kabra; Anant Mohan; Rama Chaudhry; Lalit Kumar; Sada Nand Dwivedi; Sanjay K Agarwal
Journal:  J Glob Antimicrob Resist       Date:  2019-01-15       Impact factor: 4.035

7.  Hypercalcemia Heralding Pneumocystis jirovecii Pneumonia in an HIV-Seronegative Patient with Diffuse Cutaneous Systemic Sclerosis.

Authors:  Quentin Binet; Jacques Mairesse; Marie Vanthuyne; Jean-Christophe Marot; Grégoire Wieers
Journal:  Mycopathologia       Date:  2019-11-15       Impact factor: 2.574

Review 8.  High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure.

Authors:  Suhail Raoof; Stefano Nava; Charles Carpati; Nicholas S Hill
Journal:  Chest       Date:  2020-07-15       Impact factor: 9.410

9.  Ability of quantitative PCR to discriminate Pneumocystis jirovecii pneumonia from colonization.

Authors:  Thomas Perret; Antonios Kritikos; Philippe M Hauser; Malcolm Guiver; Alix T Coste; Katia Jaton; Frederic Lamoth
Journal:  J Med Microbiol       Date:  2020-04-28       Impact factor: 2.472

10.  End-of-life home care of an interstitial pneumonia patient supported by high-flow nasal cannula therapy: A case report.

Authors:  Ken Goda; Tsuneaki Kenzaka; Kyosuke Kuriyama; Masahiko Hoshijima; Hozuka Akita
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.